
What We're Reading: Valeant Increases Aid-in-Dying Drug Price Ahead of California's New Law
What we're reading, March 24, 2016: Valeant doubles the price of aid-in-dying drug; the Supreme Court seems split on contraception case; and less than 3% of Americans meet qualifications for a healthy lifestyle.
With legalized assisted suicide ready to take effect in California starting in June, Valeant Pharmaceuticals has increased the cost of the drug used for these instances.
On Wednesday, the Supreme Court, still 1 member short, heard arguments regarding the Affordable Care Act’s contraception coverage requirement. However, it seems like a 4-4 tie may be a real possibility, which would not set a national precedent and would affirm the appeals court decisions,
Nearly all Americans do not meet the basic qualifications for a “healthy lifestyle.” Just 3% of Americans have a lifestyle that includes moderate or vigorous exercise for at least 150 minutes a week; a diet score in the top 40% of the Healthy Eating Index; no smoking; and a body fat percentage under 20% for me or 30% for women,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.